Community Health Systems Q3 2026 EBITDA Falls as Same-Store Volumes Grow

TradingKey10-30

Community Health Systems Inc. (NYSE: CYH) reported lower third-quarter revenue and adjusted EBITDA as consolidated patient volumes declined, even as its same-store hospitals recorded growth across admissions, surgeries and emergency-room visits. The hospital operator also projected a full-year net loss and disclosed a sharp increase in uncompensated care.

Net operating revenue fell 10.7% year over year to $2.76 billion for the three months ended Sept. 30, 2026. Adjusted EBITDA declined 25.5% to $280 million, while the adjusted EBITDA margin narrowed by 200 basis points to 10.2%.

The company posted a net loss attributable to Community Health Systems stockholders of $86 million, compared with net income of $130 million a year earlier. The reported diluted loss was $0.63 per share, versus earnings of $0.96 per share in the prior-year quarter. Excluding specified adjustments, the diluted loss was $0.48 per share, compared with adjusted earnings of $1.27 per share.

Same-store activity remains positive

Consolidated admissions decreased 12.3%, adjusted admissions fell 11.9%, surgeries declined 15.1% and emergency-room visits were down 13.1% from the third quarter of 2025. On a same-store basis, however, admissions increased 2.2%, adjusted admissions rose 3.6%, surgeries grew 2.0% and emergency-room visits advanced 3.6%.

Same-store net operating revenue increased 3.8%, while net revenue per adjusted admission rose 0.2% on a consolidated basis and 1.0% at same-store facilities.

For the first nine months of 2026, net operating revenue decreased 8.9% to $8.55 billion. Adjusted EBITDA fell 18.8% to $918 million, and the adjusted EBITDA margin contracted by 140 basis points to 10.7%. Same-store revenue grew 2.9% over that period, supported by increases of 0.7% in admissions, 1.9% in adjusted admissions and 0.7% in emergency-room visits. Same-store surgeries declined 0.4%.

The nine-month net loss attributable to stockholders was $74 million, compared with net income of $399 million in the prior-year period. Excluding adjustments, the diluted loss was $1.15 per share, versus earnings of $1.20 per share a year earlier.

Uncompensated care increases

Managed care and other payors accounted for 46.1% of third-quarter net revenue, down from 48.5% a year earlier. Medicare managed care increased to 19.0% from 17.2%, while Medicaid represented 16.2%, Medicare 17.0% and self-pay 1.7%.

Total consolidated uncompensated care rose to 32.9% of adjusted net revenue from 25.2% in the third quarter of 2025. The measure includes uncollectible revenue, charity care and administrative self-pay discounts.

Debt declines, operating cash flow remains limited

Community Health Systems ended September with $9.59 billion of total debt, down from $10.40 billion at the end of 2025. All debt was fixed-rate as of Sept. 30. Total assets declined to $12.11 billion from $13.20 billion, while the stockholders’ deficit widened to $1.49 billion from $1.39 billion.

Days revenue outstanding for same-store hospitals, adjusted for receivables tied to state Medicaid supplemental payment programs, increased to 59 days from 54 days at year-end 2025.

Adjusted cash flow from operations totaled $15 million for the first nine months, excluding $70 million of cash taxes paid from divestiture proceeds. Capital expenditures were $239 million, representing 2.8% of net operating revenue, compared with $241 million and 2.6% of revenue in the prior-year period.

2026 outlook

Community Health Systems expects full-year net operating revenue of $11.3 billion to $11.5 billion and adjusted EBITDA of $1.23 billion to $1.28 billion. The company projects a diluted net loss of $1.70 to $1.60 per share, based on approximately 136 million weighted-average diluted shares.

Management also forecasts net cash provided by operating activities of $100 million to $300 million and capital expenditures of $350 million to $400 million. Depreciation and amortization are expected to equal 3.8% to 3.9% of revenue.

The company cautioned that its projections are subject to regulatory, economic and competitive uncertainty. Identified risks include changes to Medicare, Medicaid and Affordable Care Act coverage; reimbursement pressure; labor costs and staffing challenges; collectability of patient receivables; cybersecurity incidents; legal and regulatory proceedings; and the company’s substantial debt and refinancing obligations.

Find out more

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment